Society ❯ Economics ❯ Market Behavior

Investor Relations

Corporate Governance Public Offerings Shareholder Value Retail Investors Venture Capital Shareholder Advocacy

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline as Securities Case Advances in SDNY

Plaintiffs allege MoonLake overstated sonelokimab’s Nanobody benefits in light of Phase 3 results that failed to show superior efficacy.

Cytokinetics Faces Investor Class Action Over Aficamten REMS Disclosures as Lead-Plaintiff Deadline Nears

Police Bar HYBE Chairman Bang Si-hyuk From Leaving South Korea in IPO Stock-Fraud Probe